Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
.11 and Up!
»
NRGX Gene therapy
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by BooDog: [QB] Interesting puzzle… NEUROLOGIX INC/DE Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits http://biz.yahoo.com/e/071204/nrgx.ob8-k.html John E. Mordock, President and Chief Executive Officer On December 4, 2007, Neurologix, Inc. (the "Company") and John E. Mordock, the Company's President and Chief Executive Officer, entered into an employment agreement (the "Mordock Employment Agreement"). The Mordock Employment Agreement is more fully described on the Company's Current Report on Form 8-K that was filed with the Securities and Exchange Commission on September 20, 2007. The Mordock Employment Agreement is attached hereto as Exhibit 10.1 and incorporated by reference herein. Marc Panoff, Chief Financial Officer, Treasurer and Secretary On December 4, 2007, the Company and Marc Panoff, the Company's Chief Financial Officer, Treasurer and Secretary, entered into an employment agreement (the "Panoff Employment Agreement"). The Panoff Employment Agreement is more fully described on the Company's Current Report on Form 8-K that was filed with the Securities and Exchange Commission on September 20, 2007. The Panoff Employment Agreement is attached hereto as Exhibit 10.2 and incorporated by reference herein. -------------------------------------------------------- FORM 8-K September 20, 2007 [URL=http://yahoo.brand.edgar-online.com/fetchFilingFrameset.aspx?FilingID=5444986&Type=HTML]http://yahoo.brand.edgar-online.com/fetchFilingFrameset.aspx?FilingID=5444986&Ty pe=HTML[/URL] ------------------------------------------- Neurologix Completes $15 Million Private Placement Monday November 26, 8:55 am ET http://biz.yahoo.com/bw/071126/20071126005304.html?.v=1 …The proceeds from the transaction, net of expenses, will be used to finance its Phase II clinical trial for the treatment of Parkinson’s disease, its Phase I clinical trial for the treatment of epilepsy, and for corporate purposes…. ------------------------------------------- Neurologix Receives Grant from the Epilepsy Research Foundation for Gene Transfer Research Tuesday December 4, 8:31 am ET http://biz.yahoo.com/bw/071204/20071204005173.html?.v=1 …biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today the receipt of a grant from the Epilepsy Research Foundation (ERF), a unique joint venture of three non-profit epilepsy organizations -- the Epilepsy Therapy Project (ETP), Epilepsy Foundation (EF), and Finding a Cure for Epilepsy and Seizures (FACES) -- to identify and accelerate the development of promising epilepsy research. The grant will help fund a Phase I human clinical study of Neurologix’s proprietary gene transfer approach to the treatment of epilepsy. The Company expects to initiate this study by early 2008, subject to final authorization from the United States Food and Drug Administration…. …Neurologix seeks to inhibit seizures caused by temporal lobe epilepsy and to reduce the invasiveness of current surgical treatment approaches by targeting a specific area within the brain, called the hippocampus, and delivering healthy genes where faulty or diminishing ones are causing the central nervous system disorder. In particular, Neurologix will seek to deliver the human Neuropeptide Y (NPY) gene, one of the brain’s endogenous anticonvulsants, to neurons in the hippocampus where NPY will act on receptors to inhibit the brain over-activity that occurs during seizures. This approach builds on experience Neurologix has gained through its similar gene transfer approach to treating Parkinson’s disease, where the company is preparing to begin Phase II human clinical trials…. -------------------------------------------- All in all, early ’08 looks to be pretty exciting. Not to say management and others won’t be taking their homage along the way. [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2